Michael D. Rogers
Plus aucun poste en cours
Profil
Michael D.
Rogers served as Chief Development Officer at Chimerix, Inc. from 2013 to 2016, and at Pharmasset, Inc. from 2007 to 2012.
Prior to that, he was Vice President of the Viral Diseases Division at GSK Plc from 2001 to 2007.
Rogers holds a graduate and doctorate degree from The University of North Carolina at Charlotte.
Anciens postes connus de Michael D. Rogers
| Sociétés | Poste | Fin |
|---|---|---|
| CHIMERIX, INC. | Corporate Officer/Principal | 30/06/2016 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Corporate Officer/Principal | 13/01/2012 |
| GSK PLC | Corporate Officer/Principal | 01/01/2007 |
Formation de Michael D. Rogers
| The University of North Carolina at Charlotte | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| CHIMERIX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
